CytoSorbents Corp (CTSO)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$0.624

Buy

$0.6496

arrow-down$-0.0081 (-1.26%)

Prices updated at 19 Dec 2025, 21:56 EST

Prices minimum 15 mins delay

Prices in USD

CytoSorbents Corp is a immunotherapy company. The Company uses blood purification to modulate inflammation with the goal of preventing or treating multiple organ failure in life-threatening illnesses and cardiac surgery.

NASDAQ

1.31%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$0.67 - $0.62
	$1.61 - $0.60
	-
	40.80m
	-
	-
	280,621
	4.52
	162,447.88
	1.62
	55.10m
	US23283X2062
	-0.18
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.